Section Arrow
Quote
BCTX.NASDAQ
- Briacell Therapeutics Corp NEW
Quotes are at least 15-min delayed:2025/11/15 19:31 EST
Regular Hours
Last
 9.165
-0.575 (-5.90%)
Day High 
9.8099 
Prev. Close
9.74 
1-M High
14.68 
Volume 
38.88K 
Bid
9
Ask
10.9
Day Low
9.11 
Open
9.64 
1-M Low
9.43 
Market Cap 
18.35M 
Currency USD 
P/E -- 
%Yield -- 
10-SMA 10.39 
20-SMA 11.51 
50-SMA 10.85 
52-W High 190.5 
52-W Low 3.410933 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-62.19/-34.00
Enterprise Value
18.38M
Balance Sheet
Book Value Per Share
9.49
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
0
Operating Revenue Per Share
--
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
ASBPAspire Biopharma Holdings Inc.0.1063+0.0011+1.05%-- 
CYPHCypherpunk Technologies Inc.2.75+0.99+56.25%-- 
IVVDInvivyd2.35+0.58+32.77%-- 
APLTApplied Therapeutics0.2183-0.0517-19.15%-- 
RXRXRecursion Pharmaceuticals4.14-0.19-4.39%-- 
Quotes are at least 15-min delayed：2025/11/15 19:31 EST
Industry overview quotes are at least 15 minutes delayed
Business Description
BriaCell Therapeutics Corp is a clinical-stage biotechnology company focused on developing immunotherapies for cancer treatment, particularly breast cancer. The company's targeted immunotherapy program, Bria-IMT, is a targeted cell-based immunotherapy in end-stage clinical trials aiming to improve outcomes for patients with breast cancer. BriaCell also develops Bria-OTS, personalized off-the-shelf immunotherapies for breast and prostate cancer. BriaCell is involved in clinical collaborations to explore combination therapies for enhanced cancer treatment options.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.